168. The Effect of Fatty Acid Amide Hydrolase Inhibition on Sleep Architecture in Cannabis Withdrawal
Patrick D. Skosnik(Connecticut Mental Health Center), Deepak Cyril D’Souza(Yale University), Mohini Ranganathan(Yale University), Peter Morgan(Yale University), Gina Creatura(Temple University), Toral Surti(Yale University), Jose Cortes-Briones(VA Connecticut Healthcare System), Emma Deaso(Yale University)
Cited by 1
Related Papers
The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial
|Psychopharmacology|2018|235
Rapid Changes in Cannabinoid 1 Receptor Availability in Cannabis-Dependent Male Subjects After Abstinence From Cannabis
|Biological Psychiatry Cognitive Neuroscience and Neuroimaging|2015|210
Efficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: a double-blind, placebo-controlled, parallel group, phase 2a single-site randomised controlled trial
|The Lancet Psychiatry|2018|194
Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trial
|Journal of Psychopharmacology|2023|152